| NCT Number | NCT07510087 |
| Lead Sponsor | Marc Toeteberg-Harms |
| Conditions | Glaucoma |
| Enrollment | 5,000 participants |
| Start Date | 2024-12-30 |
| Primary Completion | 2026-11-30 (estimated) |
| Study Completion | 2027-05-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-06 |